Cognetivity Neurosciences Ltd. operates as a technology company. The company is headquartered in Vancouver, British Columbia. The firm has developed a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical and commercial environments and other neurological conditions. The Company’s CognICA uses artificial intelligence and machine learning technology to test the performance of large areas of the brain to help detect early signs of cognitive dysfunction. The company is also focused on developing the ICA for home use, for the remote monitoring of patient’s progress under treatment regimens and for general home healthcare check-ups. CognICA is available for clinical use in the United States, United Kingdom, Europe, Canada and the Middle East. Its subsidiaries include Cognetivity Ltd. and Cognetivity FZ-LLC.
Follow-Up Questions
Who is the CEO of Cognetivity Neurosciences Ltd?
Dr. Sina Habibi is the Chief Executive Officer of Cognetivity Neurosciences Ltd, joining the firm since 2017.
What is the price performance of CGNSF stock?
The current price of CGNSF is $0, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Cognetivity Neurosciences Ltd?
Cognetivity Neurosciences Ltd belongs to N/A industry and the sector is N/A
What is Cognetivity Neurosciences Ltd market cap?
Cognetivity Neurosciences Ltd's current market cap is $0
Is Cognetivity Neurosciences Ltd a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Cognetivity Neurosciences Ltd, including 1 strong buy, 3 buy, 1 hold, 0 sell, and 1 strong sell
